A researcher has hailed "exciting" results from a study into a treatment for the hair loss condition alopecia areata. A relatively common condition, alopecia areata is thought to affect 1 in every 500 ...

Baricitinib was generally well-tolerated. Acne was the most common adverse event (17.6%), followed by dyslipidemia (7.8%). Asthenia, elevated liver enzymes, and weight gain each occurred in fewer than ...

Here are the top 5 most-viewed alopecia content in 2025.

Look, I know you’re probably not gonna believe this: people now regrow their hair with lasers. Not even surgery or chemicals.

Back in October, the 2025 Fall Clinical Dermatology Conference showcased some of the most exciting advances in skin disease treatment this year. From pill-based TYK2 inhibitors and durable IL-23 ...

Despite being unable to declare statistical success, the company claimed its therapy showed enough promise to support moving ...

Clascoterone 5%, a topical anti-androgen drug indicated for male pattern hair loss, demonstrated significant hair regrowth ...

A medication that has been found to effectively treat the skin disease alopecia areata in adults is also successful in treating adolescent patients, according to a Yale-led clinical trial. Alopecia ...

The U.S. Food and Drug Administration on Friday approved an alopecia treatment for kids, marking a historic first. The drug, ritlecitinib, is a once-daily pill for kids ages 12 and older with severe ...

LEXINGTON - The FDA just approved the first treatment of alopecia areata or baldness. The drug known as Olumiant from Eli Lilly works by blocking the immune system from attacking hair follicles. And ...

A new study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug. The study is based on Phase 3 clinical trials using ...